Free Trial

Raymond James Financial Inc. Purchases Shares of 492,046 Oscar Health, Inc. (NYSE:OSCR)

Oscar Health logo with Finance background

Raymond James Financial Inc. bought a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 492,046 shares of the company's stock, valued at approximately $6,613,000. Raymond James Financial Inc. owned 0.20% of Oscar Health as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Straightline Group LLC acquired a new stake in Oscar Health in the 4th quarter valued at approximately $205,000. Russell Investments Group Ltd. boosted its position in Oscar Health by 63.3% during the fourth quarter. Russell Investments Group Ltd. now owns 216,782 shares of the company's stock worth $2,914,000 after purchasing an additional 84,029 shares during the period. ExodusPoint Capital Management LP acquired a new position in shares of Oscar Health in the fourth quarter valued at $2,556,000. Geode Capital Management LLC lifted its stake in shares of Oscar Health by 3.0% during the 4th quarter. Geode Capital Management LLC now owns 4,468,098 shares of the company's stock worth $60,065,000 after buying an additional 128,458 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in shares of Oscar Health by 1.1% during the 4th quarter. Alliancebernstein L.P. now owns 243,160 shares of the company's stock worth $3,268,000 after buying an additional 2,600 shares during the period. 75.70% of the stock is owned by institutional investors.

Oscar Health Price Performance

Shares of NYSE OSCR traded up $0.22 during mid-day trading on Friday, reaching $12.25. The company had a trading volume of 3,593,852 shares, compared to its average volume of 3,893,885. The firm has a market cap of $3.07 billion, a price-to-earnings ratio of -612.19 and a beta of 1.75. The business's 50-day simple moving average is $13.56 and its 200 day simple moving average is $14.82. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price objective for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Oscar Health has an average rating of "Hold" and a consensus price target of $20.21.

Get Our Latest Stock Analysis on OSCR

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines